Impax Laboratories Inc (NASDAQ:IPXL)

20.30
Delayed Data
As of Feb 23
 -0.20 / -0.98%
Today’s Change
7.75
Today|||52-Week Range
25.70
+21.92%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close20.50
Today’s open20.45
Day’s range20.20 - 21.45
Volume1,020,728
Average volume (3 months)1,282,394
Market cap$1.5B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-1,327.78%
Earnings growth (this year)-45.29%
Earnings growth (next 5 years)+12.91%
Revenue growth (last year)-4.19%
P/E ratioNM
Price/Sales1.14
Price/Book2.40

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...-0.58-6.55%
RGENRepligen Corp+0.39+1.11%
ARRYArray Biopharma Inc+0.26+1.45%
EBSEmergent BioSolution...-1.22-2.47%
Data as of 4:02pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)$0.11
Annual revenue (last year)$824.4M
Annual profit (last year)-$472.0M
Net profit margin-57.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts